R H Olie - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

International Journal of Laboratory Hematology|May 10, 2018

Direct oral anticoagulants: When to consider laboratory testing?H Ten Cate, R H Olie, A J Ten Cate-Hoek, et al.

Handbook of Experimental Pharmacology|August 11, 2020

Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and AtherothrombosisR H Olie, P E J van der Meijden, H M H Spronk, et al.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 1, 2021

Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse eventsR H Olie, P E J van der Meijden, M J A Vries, et al.

Frontiers in Cardiovascular Medicine|June 28, 2021

Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet TherapyC P D M de Breet, S Zwaveling, M J A Vries, et al.

Thrombosis and Haemostasis|January 30, 2018

Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on ThrombosisH M H Spronk, T Padro, J E Siland, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

International Journal of Laboratory Hematology|May 10, 2018

Direct oral anticoagulants: When to consider laboratory testing?H Ten Cate, R H Olie, A J Ten Cate-Hoek, et al.

Handbook of Experimental Pharmacology|August 11, 2020

Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and AtherothrombosisR H Olie, P E J van der Meijden, H M H Spronk, et al.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 1, 2021

Antithrombotic therapy in high-risk patients after percutaneous coronary intervention; study design, cohort profile and incidence of adverse eventsR H Olie, P E J van der Meijden, M J A Vries, et al.

Frontiers in Cardiovascular Medicine|June 28, 2021

Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet TherapyC P D M de Breet, S Zwaveling, M J A Vries, et al.

Thrombosis and Haemostasis|January 30, 2018

Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on ThrombosisH M H Spronk, T Padro, J E Siland, et al.

Pageof 1